DiscoveryBioMed Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 7

Employees

  • Latest Deal Type
  • M&A

  • Investors
  • 1

DiscoveryBioMed General Information

Description

Operator of a medical technology research platform intended to find treatments for kidney diseases. The company's platform integrates human cell research at any and all points within the drug discovery critical path, from high-throughput screening(HTS) cell assay development and optimization to lead prioritization, enabling medical centers to treat genetic renal disorders and prevent kidney failures.

Contact Information

Website
www.discoverybiomed.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 400 Riverhills Business Park
  • Suite 435
  • Birmingham, AL 35242-8101
  • United States
+1 (205)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Acquirer
Eurofins Discovery
Vertical(s)
Life Sciences
Corporate Office
  • 400 Riverhills Business Park
  • Suite 435
  • Birmingham, AL 35242-8101
  • United States
+1 (205)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

DiscoveryBioMed Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
16. Merger/Acquisition 05-Jul-2022 Completed Generating Revenue
15. Grant 29-Apr-2020 Completed Generating Revenue
14. Grant 01-Jun-2019 Completed Generating Revenue
13. Grant 01-Jan-2019 Completed Generating Revenue
12. Grant 08-Jun-2016 Completed Generating Revenue
11. Grant 07-Oct-2014 Completed Generating Revenue
10. Later Stage VC 27-Jan-2014 Cancelled Generating Revenue
9. Grant 02-Jul-2013 Completed Generating Revenue
8. Grant 01-Jan-2012 $873K Completed Generating Revenue
7. Accelerator/Incubator 14-Sep-2011 Completed Startup
To view DiscoveryBioMed’s complete valuation and funding history, request access »

DiscoveryBioMed Patents

  • 54

    Total Documents Applications and Grants

  • Total Patents Families

  • 13

    Granted

  • 1

    Pending

  • Expiring in next 12 mo

DiscoveryBioMed Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2022192668-A1 Human taste bud tissue-derived cells and uses thereof Inactive 12-Mar-2021
CA-3142263-A1 Human diseased and normal kidney epithelial cell cultures and uses thereof Pending 30-May-2019
EP-3976758-A1 Human diseased and normal kidney epithelial cell cultures and uses thereof Inactive 30-May-2019
EP-3976758-A4 Human diseased and normal kidney epithelial cell cultures and uses thereof Inactive 30-May-2019
GB-2599815-A Human diseased and normal kidney epithelial cell cultures and uses thereof Inactive 30-May-2019 C12N5/0686
To view DiscoveryBioMed’s complete patent history, request access »

DiscoveryBioMed Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

DiscoveryBioMed Former Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
Greer Capital Advisors Venture Capital Minority
Innovation Depot Accelerator/Incubator Minority
National Center For Complementary And Integrative Health Government
National Institute of Diabetes and Digestive and Kidney Diseases Government
National Institute of Environmental Health Sciences Government
You’re viewing 5 of 9 investors. Get the full list »

Ready to get started?

Request a free trial

DiscoveryBioMed FAQs

  • When was DiscoveryBioMed founded?

    DiscoveryBioMed was founded in 2007.

  • Where is DiscoveryBioMed headquartered?

    DiscoveryBioMed is headquartered in Birmingham, AL.

  • What is the size of DiscoveryBioMed?

    DiscoveryBioMed has 7 total employees.

  • What industry is DiscoveryBioMed in?

    DiscoveryBioMed’s primary industry is Drug Discovery.

  • Is DiscoveryBioMed a private or public company?

    DiscoveryBioMed is a Private company.

  • What is DiscoveryBioMed’s current revenue?

    The current revenue for DiscoveryBioMed is .

  • Who are DiscoveryBioMed’s investors?

    Greer Capital Advisors, Innovation Depot, National Center For Complementary And Integrative Health, National Institute of Diabetes and Digestive and Kidney Diseases, and National Institute of Environmental Health Sciences are 5 of 9 investors who have invested in DiscoveryBioMed.

  • When was DiscoveryBioMed acquired?

    DiscoveryBioMed was acquired on 05-Jul-2022.

  • Who acquired DiscoveryBioMed?

    DiscoveryBioMed was acquired by Eurofins Discovery.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process